The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...
MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...
Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year. It requires careful calculations of insulin needs and bothersome daily ...
People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...
An international expert panel has recently released a comprehensive set of recommendations for optimal insulin injection techniques and equipment. The group, called the Forum for Injection Technique ...
A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
The study highlights the effect of a new once-a-week injectable insulin therapyiStock According to a new study, treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy ...
To reduce these obstacles, researchers around the world are looking for more patient-friendly ways of delivering insulin. Recently, a team from the U.S., Canada, Denmark, the United Kingdom, Poland, ...
Hosted on MSN
What Is Regular Insulin?
Regular (R) insulin is a short-acting, injectable insulin used for the management of diabetes. It is typically taken before meals to prevent glucose from rising after a person eats. Regular insulin is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results